Evaluating Cardiotoxicity in Breast Cancer Patients Treated with HER2 Inhibitors: Could a Combination of Radionuclide Ventriculography and Cardiac Biomarkers Predict the Cardiac Impact? [PDF]
Cancers (Basel), 2022 Simple Summary Breast cancer is the most frequently diagnosed cancer in women, causing over 500,000 deaths worldwide. Human epidermal growth factor receptor 2 is overexpressed in roughly 15–20% of the breast cancer cases diagnosed nowadays, denoting poor
Gherghe M +7 more
europepmc +4 more sources
The time for radionuclide ventriculography resurrection is coming [PDF]
Journal of Nuclear Cardiology, 2015 n ...
Raffaele Giubbini, Elisa Milan
semanticscholar +6 more sources
Radionuclide ventriculography phase analysis for risk stratification of patients undergoing cardiotoxic cancer therapy. [PDF]
J Nucl Cardiol, 2022 Accurate diagnostic tools to identify patients at risk of cancer therapy-related cardiac dysfunction (CTRCD) are critical. For patients undergoing cardiotoxic cancer therapy, ejection fraction assessment using radionuclide ventriculography (RNVG) is ...
Jones KA +7 more
europepmc +2 more sources
Comparison between Radionuclide Ventriculography and Echocardiography for Quantification of Left Ventricular Systolic Function in Rats Exposed to Doxorubicin. [PDF]
Arq Bras Cardiol, 2017 Background Radionuclide ventriculography (RV) is a validated method to evaluate the left ventricular systolic function (LVSF) in small rodents. However, no prior study has compared the results of RV with those obtained by other imaging methods in this ...
Oliveira LF +6 more
europepmc +2 more sources
BNP predicts chemotherapy-related cardiotoxicity and death: comparison with gated equilibrium radionuclide ventriculography. [PDF]
PLoS One, 2014 Cardiotoxicity is a dose-limiting side-effect of cancer chemotherapeutics such as anthracyclines. The drug-induced cardiac toxicity is currently monitored with repeated assessments of the left ventricular ejection fraction (LVEF) using multigated ...
Skovgaard D, Hasbak P, Kjaer A.
europepmc +2 more sources
Determination of Diastolic Function by Radionuclide Ventriculography [PDF]
Mayo Clinic Proceedings, 1990 Diastolic filling can be measured by radionuclide ventriculography with use of several techniques including those based on gated and list-mode acquisitions, the first-pass method, and the nuclear probe. Radionuclide ventriculography specifically assesses volumes, rates of volume change, and intervals during ventricular filling.
Ian P. Clements +4 more
openalex +4 more sources
Ventricular function by radionuclide ventriculography in malignant hypertension. [PDF]
Hypertension, 1992 Malignant hypertension is a unique and natural model for the study of abnormalities of left ventricular function due to arterial hypertension, because the development and regression of these abnormalities can be observed in a short period. Studies of ventricular function by radionuclide ventriculography, either before or after therapy, have not been ...
H B Silva +6 more
openalex +4 more sources
Nuclear medicine review. Central & Eastern Europe, 2012 BACKGROUND Multidrug chemotherapy increases the efficacy of the treatment, but at the same time rises its cardiotoxicity. The majority of cardiac complications are caused by anthracyclines.Radiation therapy may intensify cardiotoxicity.
Grażyna Łapińska +2 more
openalex +3 more sources
Non-invasive measurement of left ventricular function in coronary artery disease. Comparison of first pass radionuclide ventriculography, M-mode echocardiography, and systolic time intervals. [PDF]
British heart journal, 1981 F Basilico +4 more
openalex +2 more sources
Low-dose dobutamine radionuclide ventriculography for prediction of myocardial viability: quantitative analysis of regional left ventricular function. [PDF]
Clin Cardiol, 2000 Takeyasu N +12 more
europepmc +3 more sources